1Hollender A, Kvaloy S, Nome O, et al. Central nervous system involvement following diagnosis of non - Hodgkin' s lymphoma: a risk model. Ann Onco1,2002,13 : 1099 - 1107. 被引量：1
2Bollen EL, Brouwer RE, Hamers S, et al. Central nervous system relapse in non - Hodgkin lymphoma:a single - center study of 532 patients. Arch Neurol, 1997,54 (7) : 854 - 859. 被引量：1
3Boehme V, Zeynalova S, Kloess M, et al. Incidence and risk factors of central nervous system recurrence in ~aggressive lymphoma - a survey of 1693 patients treated in protocols of the German High - Grade Non - Hodgkin' s Lymphoma Study Group (DSHNHL). Ann Oncol, 2007,18 : 149 - 157. 被引量：1
4Montoto S, Lister TA. Secondary eentral nervous system lymphoma: risk factors and prophylaxis. Hematol Oneol Clin North Am,2005, 19:751 - 763. 被引量：1
5Steven H, Bernstein, Joseph M, et al. Natural history of CNS relapse in patients with aggressive non - Hodgkin's lymphoma: a 20 - year follow - up analysis of SWOG 8516 - The Southwest Oncology Group. Journal of Clinical Oncology, 2009, 18 ( 1 ) : 114 - 119. 被引量：1
6Colocci N, Glantz M, Recht L. Prevention and treatment of central nervous system involvement by non - Hodgkin's lymphoma: a review of the literature. Semin Neurol, 2004, 24 : 395 - 404. 被引量：1
7Bierman P, Giglio P. Diagnosis and treatment of central nervous system involvement in non - Hodgkin's lymphoma. Hematol Oncol Clin North Am, 2005, 19:597 -609. 被引量：1
8John T Sandlund, Sharon B Murphy, Victor bi Santana, et al. JCO 2000 CNS involvement newly diagnosed NHL (St Jude). Journal of Clinical Oncology, 2000, 18(16) : 3018 -3024. 被引量：1
9Upendra Hegde, Armando Filie, Richard F Little, et al. High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B - cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood, 2005, 105(2) :496 -502. 被引量：1
10Koen van Besien, Chul S Ha, Sandy Murphy, et al. Risk Factors, treatment, and outcome of central nervous system recurrence in a- dults with intermediate - grade and immunoblastie lymphoma. Blood, 1998, 91(4) : 1178 -1184. 被引量：1
